{{Drugbox
| Verifiedfields = 
| Watchedfields = 
| verifiedrevid = 
| IUPAC_name = (4aS,4bR,5S,6aS,6bS,8R,9aR,10aS,10bS,12S)-4b,12-Difluoro-6b-glycoloyl-5-hydroxy-4a,6a-dimethyl-8-propyl-3,4,4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-tetradecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
| image = 
| width = 

<!--Clinical data-->
| tradename = 
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category = 
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = 
| legal_UK = 
| legal_US = 
| legal_status = 
| routes_of_administration = 

<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 
| excretion =

<!-- Identifiers -->
| CAS_number_Ref = 
| CAS_number = 144459-70-1
| CAS_supplemental = 
| class = [[Corticosteroid]]; [[Glucocorticoid]]
| ATC_prefix = 
| ATC_suffix = 
| ATC_supplemental = 
| PubChem = 3055174
| IUPHAR_ligand = 
| DrugBank_Ref = 
| DrugBank = 
| ChemSpiderID_Ref = 
| ChemSpiderID = 2316734
| UNII = R9IQ7GVL3E
| KEGG = 
| ChEBI = 
| ChEMBL = 

<!--Chemical data-->
| C=25 | H=34 | F=2 | O=6
| molecular_weight = 468.538 g/mol
| SMILES = CCC[C@@H]1O[C@@H]2C[C@H]3[C@@H]4C[C@@H](C5=CC(=O)CC[C@@]5([C@]4([C@H](C[C@@]3([C@@]2(O1)C(=O)CO)C)O)F)C)F
| StdInChI_Ref = 
| StdInChI = 1S/C25H34F2O6/c1-4-5-21-32-20-10-14-15-9-17(26)16-8-13(29)6-7-22(16,2)24(15,27)18(30)11-23(14,3)25(20,33-21)19(31)12-28/h8,14-15,17-18,20-21,28,30H,4-7,9-12H2,1-3H3/t14-,15-,17-,18-,20+,21+,22-,23-,24-,25+/m0/s1
| StdInChIKey_Ref = 
| StdInChIKey = IXTCZMJQGGONPY-XJAYAHQCSA-N
| synonyms = 6α,9α-Difluoro-11β,16α,17α,21-tetrahydroxypregn-4-ene-3,20-dione, cyclic (''R'')-16,17-acetal with butyraldehyde; 16α,17α-[(1''R'')-butylidenebis(oxy)]-6α,9α-difluoro-11β,21-dihydroxypregn-4-ene-3,20-dione
}}

'''Rofleponide''' is a [[synthetic compound|synthetic]] [[glucocorticoid]] [[corticosteroid]] which was never marketed.<ref name="AdisInsight">http://adisinsight.springer.com/drugs/800007303</ref><ref name="pmid15144464">{{cite journal | vauthors = Ahlström-Emanuelsson C, Andersson M, Persson C, Schrewelius C, Greiff L | title = Topical treatment with aqueous solutions of rofleponide palmitate and budesonide in a pollen-season model of allergic rhinitis | journal = Clin. Exp. Allergy | volume = 34 | issue = 5 | pages = 731–5 | year = 2004 | pmid = 15144464 | doi = 10.1111/j.1365-2222.2004.1965.x | url = }}</ref><ref name="Nagaraju2013">{{cite book|author=K Nagaraju|title=Manual of Pediatric Allergy|url=https://books.google.com/books?id=h74DBAAAQBAJ&pg=PA109|date=30 November 2013|publisher=JP Medical Ltd|isbn=978-93-5090-498-5|pages=109–}}</ref><ref name="Bernstein2016">{{cite book|author=Jonathan A. Bernstein|title=Rhinitis, An Issue of Immunology and Allergy Clinics of North America, E-Book|url=https://books.google.com/books?id=FohLDAAAQBAJ&pg=PA407|date=27 May 2016|publisher=Elsevier Health Sciences|isbn=978-0-323-44468-2|pages=407–}}</ref>

==References==
{{Reflist|2}}

==External links==
* [http://adisinsight.springer.com/drugs/800007303 Rofleponide - AdisInsight]


{{Glucocorticoid receptor modulators}}

[[Category:Corticosteroid cyclic ketals]]
[[Category:Cyclic acetals with aldehydes]]
[[Category:Diketones]]
[[Category:Diols]]
[[Category:Fluoroarenes]]
[[Category:Glucocorticoids]]
[[Category:Pregnanes]]


{{steroid-stub}}